Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients

Amikacin is the antibiotic of choice for the treatment of Gram-negative infections, namely, those in neutropenic oncology patients. No populational pharmacokinetic studies are currently available reporting amikacin pharmacokinetics in neutropenic oncology patients despite their specific pathophysiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Aquino, Maria, Tinoco, Maria, Bicker, Joana, Falcão, Amílcar, Rocha, Marília, Fortuna, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952017/
https://www.ncbi.nlm.nih.gov/pubmed/36830283
http://dx.doi.org/10.3390/antibiotics12020373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952017/
https://www.ncbi.nlm.nih.gov/pubmed/36830283
http://dx.doi.org/10.3390/antibiotics12020373

Ejemplares similares